Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that pigmentation disorders in animals involve complex interactions between melanocytes and keratinocytes.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Immune therapy for cancer can cause hair loss scars in some patients.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Melatonin protects skin and hair from damage and stress by acting as an antioxidant and influencing cell growth.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Melatonin affects cell growth differently based on its concentration.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Melatonin affects skin cell growth differently based on how much and how long it's used.

Misusing topical corticosteroids can cause skin darkening and other side effects.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Bleomycin injections in mice cause skin thickening and hair loss.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Brentuximab may cause hair to regain color.

Reducing Tyrosinase prevents mature color pigment cells from forming in mouse hair.

α-Mangostin can naturally lighten skin by reducing melanin.